Pay in 4 interest-free payments of $5.31 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
BPC-157 literature and patent review
HGF promotes self-renewal and expansion of NSCs forming neurospheres
Investigational evidence base: Studied in clinical research for effects on body weight, energy intake, and metabolic markers in overweight/obesity populations
Theoretical synergy: three pathways working together Triple-pathway hypothesis: Why it might work: Non-overlapping receptor pathways Complementary not redundant Multiple appetite suppression mechanisms Enhanced metabolic effects Potential for greater weight loss than either alone Comparison to proven combinations: CagriSema (semaglutide + cagrilintide): 15-25% proven Tirzepatide alone: 15-22% proven Theoretical tirzepatide + cagrilintide: 20-30% unproven The critical problem: no clinical data What we DON'T know: Is the combination safe
US$ 21.85
US$ 27.61
US$ 22.07
